Target intelligence / Profile preview

KRABD1 antisense RNA 1 (KRABD1-AS1)

Target
KRABD1-AS1
Molecular classification
Long non-coding RNA, Antisense RNA, Non-protein coding RNA
01

Overview

KRABD1 antisense RNA 1 (KRABD1-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the KRABD1 gene locus and is also known as KRBOX1-AS1, FLJ32776, and KRBOX1 antisense RNA 1 (non-protein coding)[2]. As an antisense RNA, it does not code for protein but instead regulates gene expression through interactions with the mRNA or chromatin architecture of nearby or overlapping genes. Antisense RNAs can modulate their target genes by mechanisms including transcriptional interference, recruitment of chromatin modifiers, or influencing RNA stability and translation[1]. General functions of natural antisense RNAs include both positive and negative regulation of gene expression, with documented roles in epigenetic regulation, chromatin remodeling, and possibly cellular differentiation or disease mechanisms. As of current knowledge, there is no evidence that KRABD1-AS1 is a therapeutic target or directly implicated in major diseases such as cancer, neurodegeneration, or cardiovascular disease; it has no known pharmacological modulators or drugs targeting it[1][2]. The primary significance of KRABD1-AS1 appears to be its potential role in gene regulatory networks as part of the complex repertoire of non-coding RNAs in the human genome.

Other names
FLJ32776KRBOX1-AS1KRBOX1 antisense RNA 1 (non-protein coding)KRABD1-AS1
02

Biological functions

Regulation of gene expressionEpigenetic regulationChromatin remodeling
03

Disease associations

Other (Potential regulation of gene expression in health and disease; not directly associated with a specific disease as of current knowledge)

Beyond the preview

Go deeper on KRABD1 antisense RNA 1 (KRABD1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KRABD1 antisense RNA 1 (KRABD1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call